Paxil (paroxetine) is a selective serotonin reuptake inhibitor (SSRI), which is a class of antidepressants that is believed to work by influencing the balance of chemicals in the brain. Although paroxetine may help patients with depression, anxiety disorders, and other mental health disorders, some patients have questioned the drug’s safety... Read more »

GlaxoSmithKline (GSK) is engaging in wrongful conduct by failing to adequately disclose the risks of Zofran when used by women who are pregnant, according to a new birth defect lawsuit filed by a mother from Tennessee. The lawsuit is pending in the U.S. District Court for the Eastern District of... Read more »

  U.S. District Judge Matthew Kennelly of the Northern District of Illinois has issued a schedule of bellwether trials for six Androgel lawsuits. The trials are expected to begin in April and conclude in November of 2017. The issuance of this schedule rejected a request by the defendants to bifurcate... Read more »

Anthony R. Allen has filed a lawsuit against Johnson & Johnson and Mitsubishi Tanabe Pharm Corp. He claims that the defendants’ prescription medication, Invokana, resulted in serious injuries that could have claimed his life. Allen is an Illinois resident who began using Invokana in December of 2014. The plaintiff’s Invokana... Read more »

A California woman has filed a product lability lawsuit against Janssen Pharmaceuticals and Johnson & Johnson, alleging that the defendants’ product, Invokana, caused serious complications. Jennifer Anzo filed the Invokana lawsuit late in October 2015 in the U.S. District Court for the Eastern District of California. She is demanding compensation... Read more »

Bayer Healthcare Pharmaceuticals has reported substantial progress during the latest status conference for the multidistrict litigation (MDL) No. 2100 regarding Yaz and Yasmin lawsuits. The status conference took place early in November 2015. It was presided over by U.S. District Judge David R. Herndon of the Southern District of Illinois.... Read more »

London-based AstraZeneca failed to obtain FDA approval for a proposed diabetes drug that combines two different medications, saxagliptin and dapagliflozin. In October 2015, the FDA issued a complete response letter to the pharmaceutical giant’s application. The agency requested additional clinical research on the proposed combination drug. AstraZeneca recently released statements... Read more »

A federal judge has issued an order to remand three talc-related cancer lawsuits back to Missouri state court. The lawsuits represent 237 plaintiffs who claim that their diagnoses of ovarian cancer were linked to their use of talcum powder products. In October 2015, U.S. District Judge Catherine Perry rejected the... Read more »

The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order on October 13, 2015 to centralize all federal Zofran claims into a multidistrict litigation (MDL). The MDL is pending in the U.S. District Court for the District of Massachusetts, where it is proceeding under the direction of Judge F.... Read more »

John A. Purvis of Mississippi has filed a wrongful death lawsuit on behalf of the estate of Betty Jo Purvis. The lawsuit lists Fresenius Medical Care Holdings, Inc. as the defendant. Mr. Purvis added his short form complaint to the Granuflo multidistrict litigation (MDL) No. 2428 on September 23, 2015,... Read more »